PDCD1 and neoplasm: These unsatisfactory outcomes are linked to immunosuppressive tumor microenvironments, such as checkpoint receptor signaling (PD-1/PD-L1, CTLA-4), and immune suppressive cells, such as Tregs and MDSCs.